Edwards Lifesciences

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Edwards Lifesciences
Type Public (NYSEEW)
Industry Medical device
Founded 1958
Headquarters Irvine, California, United States
Key people Michael A. Mussallem, Chairman & CEO
Products Heart valves, Critical care technology, Cardiac surgery technology
Revenue $2.05 billion (2013)
Employees 8,700
Website [1]

Edwards Lifesciences is a medical equipment company specializing in artificial heart valves and hemodynamic monitoring. It is mostly known for a transcatheter aortic heart valve made of bovine tissue within a collapsible stainless-steel stent, deployed via catheter.[1] Their SAPIEN product is an FDA-approved device for percutaneous aortic valve replacement.[2] It is publicly traded on the NYSE under the symbol EW.


  1. ^ Visualizing the Sapien Heart Valve American Society of Mechanical Engineers - ASME
  2. ^ Edward Lifesciences Receives FDA Approval Expanding Access to Sapien Heart Valves The Wall Street Journal Online

External links[edit]